Table 1 Baseline characteristics
RituximabPlacebo
n89
Age at baseline (range)51 (22–64)54 (41–64)
Median disease duration, years (range)7.25 (1–18)8.25 (2–19)
Median fatigue VAS, mm (range)76 (61–95)69 (53–99)
IgG, g/litre (range)18.61 (12.03–29.35)20.98 (7.11–38.54)
Anti-Ro100%100%
Anti-La78%67%
SF-36 PCS (range)43.6 (24–56)36.7 (13–80)
SF-36 MCS (range)42.6 (16–62)52.1 (26–83)
  • PCS, physical component score; MCS, mental component score; SF-36, 36-item Short Form health survey; VAS, visual analogue scale.